Loeb, S., Metter, E. J., Kan, D., Roehl, K. A., & Catalona, W. J. (2012). Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer.
Styl cytowania ChicagoLoeb, Stacy, E. Jeffrey Metter, Donghui Kan, Kimberly A. Roehl, i William J. Catalona. Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer. 2012.
Styl cytowania MLALoeb, Stacy, et al. Prostate-Specific Antigen Velocity Risk Count Improves the Specificity of Screening for Clinically Significant Prostate Cancer. 2012.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..